Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain

NCT ID: NCT00443781

Last Updated: 2021-01-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to document and compare diagnostic test results and procedure safety in subjects undergoing both Functional Anaesthetic DiscographyTM (F.A.D.) and provocative discography (PD) and determine the appropriateness of the F.A.D. procedure data collection script for use in a larger clinical trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PD and F.A.D. diagnostic testing

Group Type OTHER

functional anesthetic discography

Intervention Type PROCEDURE

Functional Anesthetic Discography (F.A.D.) involves the placement and anchoring of a small catheter into a disc. After placement, functional testing is performed, in which the subject elicits his/her back pain via functional maneuvers or postures. Local anaesthetic is then delivered into the target disc through the catheter and the effect on functional back pain is noted.

provocative discography

Intervention Type PROCEDURE

Provocative discography (PD) has been used as a preoperative diagnostic tool for patients with back pain attributed to degenerative disc disease considering lumbar disc surgery. During PD, a clinically suspected disc is accessed with a needle and injected under pressure with radiopaque contrast dye. The subject rates his/her experience of pain for intensity and whether the pain is exactly the same as ("concordant") or different from ("not concordant" or "discordant") typical back pain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

functional anesthetic discography

Functional Anesthetic Discography (F.A.D.) involves the placement and anchoring of a small catheter into a disc. After placement, functional testing is performed, in which the subject elicits his/her back pain via functional maneuvers or postures. Local anaesthetic is then delivered into the target disc through the catheter and the effect on functional back pain is noted.

Intervention Type PROCEDURE

provocative discography

Provocative discography (PD) has been used as a preoperative diagnostic tool for patients with back pain attributed to degenerative disc disease considering lumbar disc surgery. During PD, a clinically suspected disc is accessed with a needle and injected under pressure with radiopaque contrast dye. The subject rates his/her experience of pain for intensity and whether the pain is exactly the same as ("concordant") or different from ("not concordant" or "discordant") typical back pain.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 21.
* Chronic axial low back pain without radicular pain for \> six months, not responding to at least three months of non-surgical management under the direction of a physician.
* One or two discs at L5/S1, L4/L5 or L3/L4 with abnormal findings by MRI, including any of the following: loss of disc hydration, loss of disc height, high intensity zone (HIZ), Modic changes at adjacent vertebral endplates, or herniation without nerve root compression.
* Subject states that he/she is willing to undergo lumbar spinal fusion, disc replacement, or other definitive treatment if eventual diagnosis supports such treatment.
* Physician believes that discography is clinically indicated for the purpose of surgical decision-making for the subject.
* Pre-treatment low back pain by numerical rating scale (NRS) score \> 4 (measured as average in last 24 hours on a 0-10 scale).
* Pre-treatment Oswestry Disability Index (ODI) \> 40 (0 - 100 scale).
* Subject states availability for all study visits.
* Subject is able to understand the risks and benefits of participating in the study and provides written informed consent.

* Abnormal neurologic exam attributable to lumbar disc disease, herniation, or lumbar stenosis.
* Back, buttock or pelvic pain suspected to be due to spinal stenosis, spinal fractures, infection, cancer, facet arthropathy or other hip or pelvis pathology.
* Schmorl's node or endplate disruption evident on MRI at L5/S1, L4/L5, or L3/L4.
* Medical history, physical examination or radiographic evidence (e.g., disc height too narrow) to suggest that either PD or F.A.D. may not be technically feasible.
* Any previous lumbar spine fusion or disc replacement.
* More than grade 1 spondylolisthesis as assessed by x-ray or MRI.
* Significant clinical comorbidity that may potentially interfere with data collection or follow-up (e.g., dementia, severe comorbid illness).
* History of major depression, psychosis or somatization disorder, or panic disorder.
* Allergy to any materials used in PD or F.A.D. devices, contrast, lidocaine, or bupivacaine.
* Any evidence of disc or systemic infection.
* Pregnant or child-bearing potential and not currently on adequate birth control method.

Exclusion Criteria

* Known osteoporosis or osteopenia, metabolic bone disorder, or history of chronic steroid use (the equivalent of 7.5 milligrams of daily prednisone use for \> 6 months).
* Suspected painful disc degeneration (based on clinical examination and MRI findings) outside of L5/S1, L4/L5 or L3/L4 levels.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Spine LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ray M Baker, MD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Rick D Guyer, MD

Role: PRINCIPAL_INVESTIGATOR

Texas Back Institute, Plano, TX

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Spine and Neurosurgery Center

Huntsville, Alabama, United States

Site Status

Spine Source

Beverly Hills, California, United States

Site Status

Pacific Spine Clinic

Escondido, California, United States

Site Status

UCSD Orthopaedic Surgery

San Diego, California, United States

Site Status

Emory Orthopaedics & Spine Center

Atlanta, Georgia, United States

Site Status

Hanover Orthopaedic Associates, Inc.

Hanover, Pennsylvania, United States

Site Status

Texas Back Institute

Plano, Texas, United States

Site Status

East Texas Medical Center

Tyler, Texas, United States

Site Status

Evergreen Surgical Center

Kirkland, Washington, United States

Site Status

Milwaukee Neurological Institute

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SP0603

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.